Targeting a key metabolic step in 'P. falciparum' offers hope for developing new treatments that don’t harm human cells
Read moreLos resultados logrados hasta el momento concluyen que estimular la producción de moléculas cAMP en ciertas neuronas del cerebro puede ayudar a recuperar el movimiento después de una lesión medula...
Read moreA team of researchers at the Sant Pau Research Institute (IR Sant Pau) has demonstrated that the plasma biomarker p-tau217, obtained through a simple blood test, can predict the clinical progression o...
Read moreEl grupo de investigación ‘Desarrollo y enfermedades musculares’ del Centro Andaluz de Biología del Desarrollo logra corregir alteraciones fisiopatológicas en modelos celulares de esta grave en...
Read moreResearchers have managed to identify biomarkers for cognitive impairment in this group of patients that could help in its diagnosis.
Read moreIt has been developed a new cell therapy based on CAR-T cells designed to simultaneously target two specific markers of T-cell acute lymphoblastic leukemia (T-ALL): the proteins CD1a and CCR9.
Read moreEl Grupo de Inmunología Tumoral de la institución académica asturiana identifica una proteína con potencial terapéutico y pronóstico en la leucemia linfática crónica
Read moreThe journal Cancer Cell has published a study led by the Hospital del Mar Research Institute, together with researchers from GEICAM, identifying malignant cells carrying the TIM-3 protein as a central...
Read moreManuel Salmeron and Xavier Rovira, who are both principal investigators at IBEC, have each been awarded an ERC Proof of Concept Grant. These prestigious grants are awarded by the European Research Cou...
Read moreInvestigadores de la Universidad Autónoma de Madrid (UAM) y el CSIC han identificado a la proteína FMNL1β como pieza clave en la secreción dirigida de vesículas en células T. El hallazgo, pub...
Read moreThis study provides the first evidence that NT-proBNP can predict disease before symptoms appear, paving the way for a new line of research already underway. The same team is now conducting a follow-u...
Read moreThe U.S. Food and Drug Administration (FDA) has granted orphan drug designation to a new gene therapy for Amyotrophic Lateral Sclerosis (ALS) developed at the Universitat Autònoma de Barcelona and li...
Read more